Evaluate the effectiveness of interventions implemented to reduce 30-day readmissions for patients with HF

Develop a coordinated multidisciplinary plan for interventions that have been shown to be effective in reducing 30-day hospital readmissions in patients with HF

Define performance measures from the National Quality Forum (NQF) and Centers for Medicare & Medicaid Services (CMS) that are relevant to heart failure (HF) readmissions

Patients with CKD and anemia experience substantially increased burdens to morbidity and mortality.

Explain the role of non-statin therapies in cardiovascular risk management. Summarize the mechanism of action, efficacy, and safety of novel agents for LDL-C and ASCVD risk reduction

Identify risk factors for significant morbidity and mortality that are associated with HF, particularly post hospitalization

Key points for incorporating PCSK9 inhibitors into clinical practice and tips to facilitate patient access will be included to broaden clinicians’ armamentarium of lipid-lowering treatments

Practical overview of current trends in treatment for chronic HF. Improve therapeutic decision making for patients with chronic HF. Reducing rehospitalizations and improving patient outcomes.

Assess the type, stage and functional classification of heart failure in hospitalized patients and develop a plan for patients hospitalized with heart failure with reduced ejection fraction (HFrEF)